Catharina Nordlund is appointed Global Head of HR for BICO Group AB (publ)
January 25, 2024 7:00 amBICO Group AB today announces the appointment of Catharina Nordlund as Global Head of HR. The role will further strengthen the Executive Management and be responsible for shaping and executing BICO’s global HR strategy in order to build a people and high-performance culture.
Catharina Nordlund has 25+ years’ experience of Human Resources (HR), Learning & Development as well as Sales and Marketing in global organizations. She has held various positions within the medtech and the life science industries at companies such as Cochlear Bone Anchored Solutions, Mölnlycke Health Care and Pfizer, and now latest as VP Global HR for Surgical Science. Her vast experience covers functional responsibility for HR as well as line manager positions within sales from the life science industry.
“Catharina’s experience of the life science industry as well as working in organizations with similar structure, need, and scope for HR as BICO makes her a good fit. This will support us in our journey building a people and high-performance culture”, says Maria Forss, CEO and President BICO Group AB.
“I’m honored to take on this opportunity and looking forward to working closely together with the executive management as well as the HR-teams in the Group, adding business value”, says Catharina Nordlund, assuming Global Head of HR, BICO Group AB.
Catharina Nordlund will be part of the Executive Management and report to the CEO and President. The Executive Management has transformed significantly with appointments of new CEO, CFO, and COO since January 2023, which has formed a new leadership at BICO.
Catharina Nordlund will assume her new position during April 2024.
For further information, please contact:
Maria Forss, President & CEO, BICO Group AB
Phone: EA Isabella Lundin +46 73 515 99 64
E-mail: mf@bico.com
The information was submitted for publication, through the agency of the contact person set out above, on January 25, 2024 at 07.00am CET.
About BICO
BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing.
The company uses bioconvergence as its operating system, combining advanced technologies with biology to streamline and automate workflows within the pharmaceutical and biopharma industries.
With 32,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,000 publications.
Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction of the world’s organ shortage and speeding up drug development to create the future of life-saving treatments.
BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com